| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6232612 | NFYB | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | SE | G0/G1 | 12 | - |
PV=0.258 FDR=0.838 FC=0.077 |
|
| 6232613 | NAP1L4 | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | SE | G0/G1 | 11 | - |
PV=1 FDR=1 FC=0.007 |
|
| 6232614 | HNRNPC | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | SE | G0/G1 | 14 | - |
PV=1 FDR=1 FC=-0.133 |
|
| 6232615 | HNRNPC | Lung | Cell line | Calu-3 | COVID-19;COVID-19 | GSE165025 | SE | G0/G1 | 14 | - |
PV=0.791 FDR=1 FC=-0.032 |
